ESPOSITO, JOSEPH, DR. – Trademark Portfolio
Entity Type: 01
ESPOSITO, JOSEPH, DR. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include METALIFE and ALIGNLIFE. The owner is based in Morton, IL.
50 Pennsylvania Court
Morton, IL 61550
Showing of trademarks Trademarks
Trademark Classifications
ESPOSITO, JOSEPH, DR.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Education; providing of training; entertainment; sporting and cultural activities
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does ESPOSITO, JOSEPH, DR. have?
ESPOSITO, JOSEPH, DR. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.
What trademark classes does ESPOSITO, JOSEPH, DR. file in?
ESPOSITO, JOSEPH, DR. files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 41 (Education & Entertainment), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are ESPOSITO, JOSEPH, DR.'s most well-known trademarks?
ESPOSITO, JOSEPH, DR.'s registered trademark portfolio includes well-known marks such as METALIFE and ALIGNLIFE. These are among 2 currently registered trademarks in the portfolio.
What is ESPOSITO, JOSEPH, DR.'s trademark registration success rate?
ESPOSITO, JOSEPH, DR. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.